Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Applicability of TachoSil in sealing rectal anastomoses
2006-003349-17Phase 3Completed
- Sponsor
- Copenhagen University Hospital - Hvidovre
- Start
- Jul 2007
- Modality
- Recombinant Proteins and Enzymes, Device-based Delivery → Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of tachosil in colorectal cancer (CRC) and anastomotic dehiscence (AD), sponsored by Copenhagen University Hospital - Hvidovre. Primary endpoint: Validation of TachoSil application procedure. Started Jul 2007; status: completed.
02
Drugs
tachosil
03
Conditions
colorectal cancer (CRC)anastomotic dehiscence (AD)
Beyond the preview
Go deeper on 2006-003349-17.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-003349-17.